• Explore /
  • Poster
  • / The association between trophoblast cell surface antigen 2 expression and nivolumab monotherapy in patients with advanced gastric cancer.

The association between trophoblast cell surface antigen 2 expression and nivolumab monotherapy in patients with advanced gastric cancer.

Abstract Poster

Authors

null

Toru Kadono

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan;

Toru Kadono , Hirokazu Shoji , Hidekazu Hirano , Natsuko Okita Okita , Satoru Iwasa , Atsuo Takashima , Ken Kato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 438)

DOI

10.1200/JCO.2023.41.4_suppl.438

Abstract #

438

Poster Bd #

K4

Abstract Disclosures

Similar Posters

First Author: Kohei Shitara

First Author: Lin Shen

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.

Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.

First Author: Mai Utsumi

First Author: Yelena Y. Janjigian